Market Tracker

10/01 10:16am ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

11.68
Real-Time Quote
 -0.24 / -2.01%
Today’s Change
2.62
Today|||52-Week Range
13.09
+247.62%
Year-to-Date

Today’s Trading

Previous close11.92
Today’s open11.89
Day’s range11.73 - 11.97
Volume309,836
Average volume (3 months)4,918,965
Market cap$2.3B
Dividend yield--
Data as of 10:01am ET, 10/01/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+44.91%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book98.13

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.23-3.89%
ACADACADIA Pharmaceutica...-0.54-2.18%
WXWuXi Pharmatech (Cay...-0.23-0.66%
THRXTheravance Inc-0.14-0.82%
Data as of 10:16am ET, 10/01/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts